You are here

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
352 Targeting glioblastoma with a TCR specific to the HLA-A*02-restricted, glioblastoma-associated antigen PTPRZ1

Authors

  • Yu-Chan Chih German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany Department of Neurology, Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, BW, Germany Faculty of Biosciences, Heidelberg University, Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Philipp Koopmann German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Amelie Christina Dietsch German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Dennis A Agardy German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany Department of Neurology, Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, BW, Germany German Cancer Research Center (dkfz), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Alice De Roia German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany Department of Neurology, Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, BW, Germany Faculty of Biosciences, Heidelberg University, Heidelberg, BW, Germany DNA Vector Laboratory, DKFZ, Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Alexandros Kourtesakis Faculty of Biosciences, Heidelberg University, Heidelberg, BW, Germany Neurology Clinic, Heidelberg University Hospital, Heidelberg, BW, Germany DKTK CCU Neurooncology, DKFZ, Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Michael Kilian German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany Department of Neurology, Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, BW, Germany PubMed articlesGoogle scholar articles
  • Christopher Krämer German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany Department of Neurology, Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, BW, Germany PubMed articlesGoogle scholar articles
  • Edward Wilhelm Green German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, BW, Germany PubMed articlesGoogle scholar articles
  • Agnieszka Blum Ardigen, Kraków, Małopolskie województwo, Poland PubMed articlesGoogle scholar articles
  • Victor Murcia Pieńkowski Ardigen, Kraków, Małopolskie województwo, Poland PubMed articlesGoogle scholar articles
  • Wolfgang Wick Neurology Clinic, Heidelberg University Hospital, Heidelberg, BW, Germany Clinical Cooperation Unit (CCU) Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Michael Platten DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Lukas Bunse DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles

Citation

Chih Y, Koopmann P, Dietsch AC, et al
352 Targeting glioblastoma with a TCR specific to the HLA-A*02-restricted, glioblastoma-associated antigen PTPRZ1
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0352
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.